financetom
Business
financetom
/
Business
/
Zoom Momentum Remains Strong With Healthy Outlook, Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zoom Momentum Remains Strong With Healthy Outlook, Wedbush Says
Aug 22, 2025 5:51 AM

08:28 AM EDT, 08/22/2025 (MT Newswires) -- Zoom Communications ( ZM ) is showing "solid momentum" with a "healthy outlook" as AI features, strength in contact center solutions and better platform adoption drive growth opportunities, Wedbush Securities said in a note Friday.

The company delivered strong fiscal Q2 results, with revenue of $1.22 billion, up 5% year over year, and adjusted EPS of $1.53, above consensus.

"The company raised its FY26 guidance across the board as Zoom continues to see greater traction for multiple products across its portfolio with expanding spend within its enterprise customer base while improving its cost management initiatives," analysts said.

According to Wedbush, the company's contact center solution saw 94% growth year over year. Additionally, the Workvivo platform saw 142% growth year over year in customers spending over $100,000.

The firm noted fourfold growth in monthly active users for Zoom's AI Companion year over year, with enterprises expanding the use of AI beyond meeting summaries.

"This was another solid quarter by Zoom as the company's new GTM strategy gains further traction," Wedbush said.

Wedbush maintained an outperform rating on the stock and price target of $95.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ecovyst, ChiralVision Collaborate on Enzyme Immobilization Technologies
Ecovyst, ChiralVision Collaborate on Enzyme Immobilization Technologies
Feb 4, 2025
09:40 AM EST, 02/04/2025 (MT Newswires) -- Ecovyst ( ECVT ) and ChiralVision said Tuesday they have signed a memorandum of understanding to advance enzyme immobilization technologies. Financial terms were not disclosed. The companies said they will develop technologies to enhance the efficiency and sustainability of enzyme-based processes. Price: 7.75, Change: +0.05, Percent Change: +0.65 ...
Freightos Names Pablo Pinillos CFO
Freightos Names Pablo Pinillos CFO
Feb 4, 2025
09:34 AM EST, 02/04/2025 (MT Newswires) -- Freightos ( CRGO ) said Tuesday that it has named Pablo Pinillos as chief financial officer, effective March 1. Pinillos was most recently CFO of Coincover, Freightos ( CRGO ) said. Price: 4.18, Change: +0.01, Percent Change: +0.24 ...
Supernus Pharmaceuticals Says Onapgo Approved by FDA for Parkinson's Disease
Supernus Pharmaceuticals Says Onapgo Approved by FDA for Parkinson's Disease
Feb 4, 2025
09:33 AM EST, 02/04/2025 (MT Newswires) -- Supernus Pharmaceuticals ( SUPN ) said Tuesday that the US Food and Drug Administration has approved its Onapgo injection to treat motor fluctuations in adults with advanced Parkinson's disease. The biopharmaceutical company said Onapgo will be available in Q2. Shares of Supernus Pharmaceuticals ( SUPN ) were up more than 4% in early...
Shares of Calvin Klein-parent PVH and Illumina fall after China targets companies
Shares of Calvin Klein-parent PVH and Illumina fall after China targets companies
Feb 4, 2025
(Reuters) - Shares of Calvin Klein-owner PVH Corp and genetic testing company Illumina ( ILMN ) fell in U.S. premarket trading on Tuesday after China placed the two companies on its unreliable entity list, making them eligible for sanctions. Companies added to the blacklist can be subject to fines and a broad range of other sanctions, including a freeze on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved